Home » Mylan Gets FDA Approval for Generic Version of Zyban
Mylan Gets FDA Approval for Generic Version of Zyban
Mylan said its subsidiary Mylan Pharmaceuticals received final approval from the
U.S. Food and Drug Administration for its Abbreviated New Drug Application for Bupropion Hydrochloride Extended-release Tablets USP, 150 mg, the generic
version of GlaxoSmithKline’s smoking cessation
aid, Zyban.
RTTNews
RTTNews
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May